Board Meeting Outcome
Outcome Of Board Meeting Under Regulations 30 Read With 33 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Vista Pharmaceuticals Ltd. Press Release May 20 2025
- Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended 31.03.2025
- Vista Pharmaceuticals Ltd. Press Release Apr 30 2025
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
- Vista Pharmaceuticals Ltd. Press Release Apr 28 2025
Later from Vista Pharmaceuticals
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Vista Pharmaceuticals Ltd. Press Release May 30 2025
- Closure of Trading Window
- Vista Pharmaceuticals Ltd. Press Release Jun 26 2025
- Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements Requirements) Regulations, 2015.
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals